The effect of vitamin C supplementation on favipiravir-induced oxidative stress and proinflammatory damage in livers and kidneys of rats

References

• Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad, Ser B, Phys Biol Sci. 2017;93(7):449–463.
   Google Scholar
• Łagocka R, Dziedziejko V, Kłos P, et al. Favipiravir in therapy of viral infections. J Clin Med. 2021;10(2):1–16.
   Web of Science ®Google Scholar
• Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. 2020;6(10):1192–1198.
   Web of Science ®Google Scholar
• Hanioka N, Saito K, Isobe T, et al. Favipiravir biotransformation in liver cytosol: species and sex differences in humans, monkeys, rats, and mice. Biopharm Drug Dispos. 2021;42(5):218–225.
   PubMed Web of Science ®Google Scholar
• Joshi S, Parkar J, Ansari A, et al. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501–508.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kulkarni A, Sharma M, et al. Favipiravir-induced liver injury in patients with coronavirus disease 2019. J Clin Transl Hepatol. 2021;9(2):276–278.
   PubMed Web of Science ®Google Scholar
• Marra F, Smolders EJ, El-Sherif O, et al. Recommendations for dosing of repurposed COVID-19 medications in patients with renal and hepatic ımpairment. Drugs R D. 2021;21(1):9–27.
   PubMed Web of Science ®Google Scholar
• Uttara B, Singh AV, Zamboni P, et al. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74.
   PubMed Web of Science ®Google Scholar
• Hosohata K. Role of oxidative stress in drug-induced kidney injury. IJMS. 2016;17(11):1826.
   Google Scholar
• Li S, Tan HY, Wang N, et al. The role of oxidative stress and antioxidants in liver diseases. IJMS. 2015;16(11):26087–26124.
   Google Scholar
• Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: evaluation of ıts role in disease prevention. J Am Coll Nutr. 2003;22(1):18–35.
   PubMed Web of Science ®Google Scholar
• Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.
   PubMed Web of Science ®Google Scholar
• Caroline AL, Powell DS, Bethel LM, et al. Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal ınhalational Rift Valley fever. PLOS Negl Trop Dis. 2014;8(4):e2790–9.
   PubMed Web of Science ®Google Scholar
• MacDonald L, Thumser AE, Sharp P. Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br J Nutr. 2002;87(2):97–100.
   PubMed Web of Science ®Google Scholar
• Ismail THB, Ali BH, Bashir AA. Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats. Gen Pharmacol. 1994;25(6):1249–1252.
   PubMedGoogle Scholar
• Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998;108:101–106.
   PubMedGoogle Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman’s reagent. Anal Biochem. 1968;25(1):192–205.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497–500.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 673–677.
   Google Scholar
• Hashemian SMR, Farhadi T, Velayati AA. A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Rev Anti Infect Ther. 2021;19(8):1029–1037.
   PubMed Web of Science ®Google Scholar
• Du YX, Chen XP. Favipiravir: pharmacokinetics and concerns About clinical trials for 2019-nCoV ınfection. Clin Pharmacol Ther. 2020;108(2):242–247.
   PubMed Web of Science ®Google Scholar
• Gowen BB, Sefing EJ, Westover JB, et al. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Antiviral Res. 2015;121:132–137.
   PubMed Web of Science ®Google Scholar
• Driouich JS, Cochin M, Lingas G, et al. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021;12(1):1–13.
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Suzuki T, Sayama M, et al. Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19. J Infect Chemother. 2021;27(2):390–392.
   PubMed Web of Science ®Google Scholar
• Ozsurekci Y, Oygar PD, Gürlevik SL, et al. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr Nephrol. 2021;36(11):3771–3776.
   PubMed Web of Science ®Google Scholar
• Gunaydin-Akyildiz A, Aksoy N, Boran T, et al. Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells. Toxicol Lett. 2022;371(June):9–16.
   PubMedGoogle Scholar
• Doğan MF, Başak Türkmen N, Taşlıdere A, et al. The protective effects of capsaicin on oxidative damage-induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Drug Chem Toxicol. 2021;45(6):2463–2470.
   PubMed Web of Science ®Google Scholar
• Oztanir MN, Dogan MF, Basak Turkmen N, et al. Secukinumab ameliorates oxidative damage induced by cerebral ischemia-reperfusion in rats. Turk Neurosurg. 2021;32(5):732–739.
   Web of Science ®Google Scholar
• Kara A, Yakut S, Caglayan C, et al. Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach. Drug Chem Toxicol. 2022;1–11.
   PubMed Web of Science ®Google Scholar
• Chen Y ,Luo G ,Yuan J, et al. Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in sev…: discovery service for endeavour college of natural health library. Mediators Inflamm. 2014;2014:426740.
   PubMed Web of Science ®Google Scholar
• Lektemur Alpan A, Torumtay Cin G, Özmen Ö, et al. Evaluation of the effects of favipiravir combined with vitamin C on alveolar bone in rats. J Evol Biochem Phys. 2022;58(2):430–440.
   PubMed Web of Science ®Google Scholar
• Ajith TA, Usha S, Nivitha V. Ascorbic acid and α-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta. 2007;375(1–2):82–86.
   PubMed Web of Science ®Google Scholar
• Rahmouni F, Badraoui R, Amri N, et al. Hepatotoxicity and nephrotoxicity in rats induced by carbon tetrachloride and the protective effects of teucrium polium and vitamin C. Toxicol Mech Methods. 2019;29(5):313–321.
   PubMed Web of Science ®Google Scholar
• Dong Y, Liu Y, Kou X, et al. The protective or damaging effect of tumor necrosis factor-aα in acute liver injury is concentration-dependent. Cell Biosci. 2016;6(1):8.
   PubMedGoogle Scholar
• Tanaka T, Narazaki M, Kishimoto T. Il-6 in inflammation, ımmunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):16295–16296.
   PubMed Web of Science ®Google Scholar
• Cárcamo JM, Pedraza A, Bórquez-Ojeda O, et al. Vitamin C suppresses TNFα-induced NFκB activation by inhibiting IκBα phosphorylation. Biochemistry. 2002;41(43):12995–13002.
   PubMed Web of Science ®Google Scholar
• Subramanian VS, Sabui S, Subramenium GA, et al. Tumor necrosis factor alpha reduces intestinal vitamin C uptake: a role for NF-κB-mediated signaling. Am J Physiol Gastrointest Liver Physiol. 2018;315(2):G241–G248.
   PubMed Web of Science ®Google Scholar